MIM
EDIT icon

Monashee Investment Management’s Editas Medicine EDIT Stock Holding History

Monashee Investment Management’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-105,000
Closed -$3.11M – 203
2020
Q2 		$3.11M Buy
+105,000
New +$2.74M 0.46% 71

Other funds holding EDIT

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Monashee Investment Management's EDIT Position: Q3 2020 in Review

Monashee Investment Management sold out of Editas Medicine (EDIT) in Q3 2020, closing a stake of 105,000 shares — an estimated $3.11M sold.

Monashee Investment Management first reported a position in EDIT in Q2 2020 and held it in 1 quarter. The position peaked at $3.11M in Q2 2020. 239 funds tracked by Wall St. Rank hold EDIT as of Q3 2020.

  • Monashee Investment Management reported no remaining Editas Medicine position as of Q3 2020 after selling out during the quarter.
  • Monashee Investment Management sold 105,000 Editas Medicine shares in Q3 2020, an estimated $3.11M.
  • Monashee Investment Management first reported a position in Editas Medicine in Q2 2020 and held it in 1 quarter.
  • Monashee Investment Management's Editas Medicine position peaked at $3.11M in Q2 2020.
  • 239 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2020.

Based on Monashee Investment Management's 13F filing for Q3 2020, filed 13 Nov 2020.